uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage
Show others and affiliations
2009 (English)In: Journal of Hypertension, ISSN 0263-6352, E-ISSN 1473-5598, Vol. 27, no 12, 2444-2451 p.Article in journal (Refereed) Published
Abstract [en]

Background and aim Angiotensin II acts through two major receptors: AT1-R and AT2-R. It is known that the stimulation of AT1-R mediates vasoconstriction, cell proliferation and fibrosis, aldosterone release and inflammatory response but, although the stimulation of AT2-R is thought to promote vasodilation and anti-inflammatory effects, its real in-vivo functions are still unclear. The aim of this study was to investigate the effects of specific and selective AT2-R stimulation on the pathological events occurring in spontaneously hypertensive stroke-prone rats (SHRSPs). Methods and results SHRSPs who were fed a high-salt diet underwent long-term treatment with vehicle or compound 21 (C21), a nonpeptide selective AT2-R agonist, at doses of 0.75, 5 and 10 mg/kg per day. The vehicle-treated rats developed brain abnormalities detectable by magnetic resonance imaging after 42.5 +/- 7.5 days, and died 43 +/- 9.5 days after the start of the dietary treatment. The highest C21 dose delayed the occurrence of brain damage (P<0.001 vs. vehicle-treated SHRSPs) and prolonged survival (P<0.001) without affecting blood pressure. These beneficial effects of C21 were abolished by the administration of PD123319, an AT2-R antagonist. C21 treatment preserved renal structure by preventing inflammatory cell infiltration, collagen accumulation, and the neo-expression of vimentin; it also prevented the increased plasma renin activity and accumulation of urinary acute-phase proteins observed in the vehicle-treated rats. Conclusion Specific and selective AT2-R stimulation has beneficial effects on the pathological events occurring in SHRSPs. These data indicate a new avenue for the pharmacological treatment of diseases in which modulation of the renin-angiotensin system is required.

Place, publisher, year, edition, pages
2009. Vol. 27, no 12, 2444-2451 p.
Keyword [en]
angiotensin type 2 receptor, fibrosis, inflammation, kidney, stroke-prone rats
National Category
Pharmaceutical Sciences
Research subject
Organic Pharmaceutical Chemistry
URN: urn:nbn:se:uu:diva-124922DOI: 10.1097/HJH.0b013e3283311ba1ISI: 000272420800020OAI: oai:DiVA.org:uu-124922DiVA: diva2:318168
Available from: 2010-05-06 Created: 2010-05-06 Last updated: 2010-06-21Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text
By organisation
Organic Pharmaceutical Chemistry
In the same journal
Journal of Hypertension
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 154 hits
ReferencesLink to record
Permanent link

Direct link